<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04917510</url>
  </required_header>
  <id_info>
    <org_study_id>IRB-21-1223</org_study_id>
    <nct_id>NCT04917510</nct_id>
  </id_info>
  <brief_title>Evaluating the Efficacy of Erector Spinae Block in Routine Hip Arthroscopy</brief_title>
  <official_title>Evaluating the Efficacy of Erector Spinae Block in Routine Hip Arthroscopy: A Prospective Analysis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Carilion Clinic</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Carilion Clinic</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this project is to evaluate the efficacy of preoperative erector spinae blocks in&#xD;
      arthroscopic hip surgery. This will be a prospective randomized controlled trial.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The aim of this project is to evaluate the efficacy of preoperative erector spinae blocks in&#xD;
      arthroscopic hip surgery. This will be a prospective randomized controlled trial. The control&#xD;
      group will not receive a preoperative block prior to surgery, but will receive local&#xD;
      anesthetic at the surgical site at the conclusion of the surgery. The study group will&#xD;
      receive a preoperative block and local anesthetic. The primary outcomes will be pain levels&#xD;
      and opioid consumption in the post-operative care unit. The secondary outcomes will be pain&#xD;
      levels and opioid consumption post-operatively, and functional outcome measures.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">July 2021</start_date>
  <completion_date type="Anticipated">August 2023</completion_date>
  <primary_completion_date type="Anticipated">June 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Patients will be randomized to either the study group or control group prior to undergoing surgery</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
    <masking_description>Erector spinae block will be performed after general anesthesia has been induced. Patients will be unaware which arm of the study they are in.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Post Anesthesia Care Unit Opioids</measure>
    <time_frame>6 hours post-operatively</time_frame>
    <description>Total morphine milligram equivalents of administered in the post-operative care unit</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Post Anesthesia Care Unit Pain</measure>
    <time_frame>6 hours post-operatively</time_frame>
    <description>Visual analogue pain score at the time of discharge from the Post Anesthesia Care Unit in which 0 equals no pain and 10 equals extreme pain</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Hip disability and Osteoarthritis Outcome Score</measure>
    <time_frame>1 year post-operatively</time_frame>
    <description>Hip disability and Osteoarthritis Outcome score at post-op visits in which 0 equals no pain and 100 equals unbearable pain</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient Reported Outcomes measurement Information System Score</measure>
    <time_frame>1 year post-operatively</time_frame>
    <description>Patient Reported Outcomes measurement Information System score at post-op visits in which 0 equals no pain and 10 equals extreme pain</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Range Of Motion</measure>
    <time_frame>1 year post-operatively</time_frame>
    <description>Hip range of motion in degrees of motion, will be examined by the operative surgeon in the office measured by flexion 0-110 degrees with 0 being no range of motion and 110 being full range of motion, internal rotation -5-25 degrees with -5 being no range of motion and -25 being full range of motion, and external rotation 0-60 degrees with 0 being no range of motion and 60 being full range of motion.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Outpatient Opioids</measure>
    <time_frame>4 weeks post discharge</time_frame>
    <description>Opioids consumed after discharge from hospital</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Outpatient Visual Analog Scale scores</measure>
    <time_frame>4 weeks post discharge</time_frame>
    <description>Pain scores each day for the first 4 weeks after surgery on the Visual Analog Scale in which 0 equals no pain and 10 equals unbearable pain</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">120</enrollment>
  <condition>Hip Disease</condition>
  <condition>Postoperative Pain</condition>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Will not receive erector spinae block. Will be administered 30 mL of 0.5% Marcaine w/ epinephrine as a local block at the surgical site at the conclusion of the procedure.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Study</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Will receive an erector spinae block prior to surgery using 30-45 mL of 0.25 bupivacaine w/ epinephrine and 5 mL of dexmedetomidine. Will be administered 30 mL of 0.5% marcaine w/ epinephrine as a local block at the surgical site at the conclusion of the procedure.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Erector spinae block</intervention_name>
    <description>See experimental arm group description</description>
    <arm_group_label>Study</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Local block</intervention_name>
    <description>See control and study arm group descriptions for the local block</description>
    <arm_group_label>Control</arm_group_label>
    <arm_group_label>Study</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  All patients undergoing hip arthroscopy for femoroacetabular impingement&#xD;
&#xD;
          -  Ages 13-50&#xD;
&#xD;
          -  Individuals who have the capacity to provide consent or assent for themselves&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Hip arthroscopy for any other reason (not undergoing labral repair, acetabuloplasty,&#xD;
             and femoral osteochondroplasty)&#xD;
&#xD;
          -  Revision surgery&#xD;
&#xD;
          -  Known narcotic use in the 6 months prior to surgery&#xD;
&#xD;
          -  Workman's compensation patient&#xD;
&#xD;
          -  Pregnancy&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>13 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Benjamin Coobs, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Carilion Clinic Ortho Surgeon</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Benjamin Coobs, MD</last_name>
    <phone>(540) 521-3830</phone>
    <email>brcoobs@carilionclinic.org</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Daniel Sveom</last_name>
    <phone>(540) 981-8050</phone>
    <email>dsveom@carilionclinic.org</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Institute for Orthopedics and Neurosciences</name>
      <address>
        <city>Roanoke</city>
        <state>Virginia</state>
        <zip>24014</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>June 2021</verification_date>
  <study_first_submitted>May 28, 2021</study_first_submitted>
  <study_first_submitted_qc>June 4, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">June 8, 2021</study_first_posted>
  <last_update_submitted>June 4, 2021</last_update_submitted>
  <last_update_submitted_qc>June 4, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">June 8, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Hip</keyword>
  <keyword>Pain</keyword>
  <keyword>Arthroscopy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pain, Postoperative</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

